tradingkey.logo
tradingkey.logo
Buscar

Tactile Systems Technology Inc

TCMD
Añadir a la lista de seguimiento
22.740USD
-0.300-1.30%
Cierre 05/15, 16:00ETCotizaciones retrasadas 15 min
512.93MCap. mercado
25.79P/E TTM

Tactile Systems Technology Inc

22.740
-0.300-1.30%

Más Datos de Tactile Systems Technology Inc Compañía

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.

Información de Tactile Systems Technology Inc

Símbolo de cotizaciónTCMD
Nombre de la empresaTactile Systems Technology Inc
Fecha de salida a bolsaJul 28, 2016
Director ejecutivoDodd (Sheri L)
Número de empleados1037
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 28
Dirección3701 Wayzata Blvd, Suite 300
CiudadMINNEAPOLIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55416
Teléfono18333822845
Sitio Webhttps://www.tactilemedical.com/
Símbolo de cotizaciónTCMD
Fecha de salida a bolsaJul 28, 2016
Director ejecutivoDodd (Sheri L)

Ejecutivos de Tactile Systems Technology Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--
Ms. Valerie L. (Val) Asbury
Ms. Valerie L. (Val) Asbury
Independent Director
Independent Director
--
--
Mr. D. Brent Shafer
Mr. D. Brent Shafer
Independent Director
Independent Director
--
--
Dr. B. Vindell Washington, M.D.
Dr. B. Vindell Washington, M.D.
Independent Director
Independent Director
--
--
Mr. Sam Bentzinger
Mr. Sam Bentzinger
Investor Relations Contact Officer
Investor Relations Contact Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Raymond O. (Ray) Huggenberger
Mr. Raymond O. (Ray) Huggenberger
Independent Director
Independent Director
62.84K
+10.38%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Chairman of the Board
Independent Chairman of the Board
55.04K
+11.85%
Ms. Elaine M. Birkemeyer
Ms. Elaine M. Birkemeyer
Chief Financial Officer
Chief Financial Officer
51.57K
-17.08%
Ms. Carmen B. Volkart
Ms. Carmen B. Volkart
Independent Director
Independent Director
44.22K
+14.75%
Ms. Sheri L. Dodd
Ms. Sheri L. Dodd
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Kristie T. Burns
Ms. Kristie T. Burns
Senior Vice President - Marketing and Clinical Affairs
Senior Vice President - Marketing and Clinical Affairs
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2023
Por negocioUSD
Nombre
Ganancia
Proporción
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Lymphedema products
278.38M
84.48%
Airway clearance products
51.14M
15.52%

Estadísticas de accionistas

Actualizado: mié., 13 de may
Actualizado: mié., 13 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Otro
72.90%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.83%
Morgan Stanley & Co. LLC
5.34%
Nomura Investment Management Business Trust
5.33%
Cadian Capital Management LP
4.81%
Dimensional Fund Advisors, L.P.
4.79%
Otro
72.90%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
43.16%
Investment Advisor/Hedge Fund
38.32%
Hedge Fund
10.28%
Research Firm
7.16%
Individual Investor
2.33%
Pension Fund
0.69%
Bank and Trust
0.42%
Family Office
0.31%
Venture Capital
0.10%

Participación institucional

Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
376
24.21M
107.32%
-2.56M
2025Q4
351
22.70M
101.64%
-5.48M
2025Q3
366
22.60M
101.18%
-8.77M
2025Q2
389
24.67M
110.65%
-7.05M
2025Q1
401
24.00M
103.20%
-7.47M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
1.54M
6.77%
-82.94K
-5.11%
Dec 31, 2025
Morgan Stanley & Co. LLC
1.20M
5.3%
-913.29K
-43.12%
Dec 31, 2025
Nomura Investment Management Business Trust
1.20M
5.29%
--
--
Mar 09, 2026
Cadian Capital Management LP
1.08M
4.77%
-971.66K
-47.27%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.10M
4.81%
-95.97K
-8.06%
Dec 31, 2025
Acadian Asset Management LLC
956.07K
4.2%
+110.62K
+13.08%
Dec 31, 2025
Paradigm Capital Management, Inc.
736.60K
3.24%
-801.80K
-52.12%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
638.37K
2.81%
+529.37K
+485.65%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Cambria Micro and SmallCap Shareholder Yield ETF
1.13%
Invesco NASDAQ Future Gen 200 ETF
0.61%
First Trust Active Factor Small Cap ETF
0.61%
Lattice Hartford Multifactor Small Cap ETF
0.58%
Federated Hermes MDT Small Cap Core ETF
0.38%
Unusual Whales Subversive Democratic Trading ETF
0.37%
iShares US Small Cap Value Factor ETF
0.33%
Royce Quant Small-Cap Quality Value ETF
0.21%
Vanguard US Multifactor ETF
0.14%
VictoryShares Small Cap Free Cash Flow ETF
0.12%
Ver más
Cambria Micro and SmallCap Shareholder Yield ETF
Proporción1.13%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.61%
First Trust Active Factor Small Cap ETF
Proporción0.61%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.58%
Federated Hermes MDT Small Cap Core ETF
Proporción0.38%
Unusual Whales Subversive Democratic Trading ETF
Proporción0.37%
iShares US Small Cap Value Factor ETF
Proporción0.33%
Royce Quant Small-Cap Quality Value ETF
Proporción0.21%
Vanguard US Multifactor ETF
Proporción0.14%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.12%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI